0001209191-23-054846.txt : 20231109 0001209191-23-054846.hdr.sgml : 20231109 20231109163646 ACCESSION NUMBER: 0001209191-23-054846 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231109 FILED AS OF DATE: 20231109 DATE AS OF CHANGE: 20231109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Paya Carlos V CENTRAL INDEX KEY: 0001606244 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39323 FILM NUMBER: 231393218 MAIL ADDRESS: STREET 1: C/O IMMUNE DESIGN CORP. STREET 2: 1616 EASTLAKE AVE. E, SUITE 310 CITY: SEATTLE STATE: WA ZIP: 98102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vaxcyte, Inc. CENTRAL INDEX KEY: 0001649094 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 464233385 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 825 INDUSTRIAL ROAD, STE. 300 CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650-837-0111 MAIL ADDRESS: STREET 1: 825 INDUSTRIAL ROAD, STE. 300 CITY: SAN CARLOS STATE: CA ZIP: 94070 FORMER COMPANY: FORMER CONFORMED NAME: SutroVax, Inc. DATE OF NAME CHANGE: 20150724 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-11-09 0 0001649094 Vaxcyte, Inc. PCVX 0001606244 Paya Carlos V C/O VAXCYTE, INC. 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 1 0 0 0 0 Common Stock 2023-11-09 4 G 0 3125 0.00 D 2500 D Common Stock 2023-11-09 4 A 0 3125 0.00 A 3125 I By Family Trust Stock Option (right to buy) 22.02 2023-11-09 4 G 0 30000 0.00 D 2031-10-26 Common Stock 30000 0 D Stock Option (right to buy) 22.02 2023-11-09 4 G 0 30000 0.00 A 2031-10-26 Common Stock 30000 30000 I By Family Trust Stock Option (right to buy) 22.70 2023-11-09 4 G 0 18750 0.00 D 2032-05-31 Common Stock 18750 0 D Stock Option (right to buy) 22.70 2023-11-09 4 G 0 18750 0.00 A 2032-05-31 Common Stock 18750 18750 I By Family Trust Stock Option (right to buy) 53.08 2023-11-09 4 G 0 15000 0.00 D 2033-06-12 Common Stock 15000 0 D Stock Option (right to buy) 53.08 2023-11-09 4 G 0 15000 0.00 A 2033-06-12 Common Stock 15000 15000 I By Family Trust The reported transactions involve the Reporting Person's transfer of certain securities to a trust for the sole benefit of the Reporting Person. As previously disclosed in Reporting Person's Form 4 filed on June 15, 2023, this represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 13, 2024 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date. Shares are held directly by a trust for the sole benefit of the Reporting Person. Option vests over 36 months, 1/3 of which will vest on October 27, 2022 and 1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date. Options are held directly by a trust for the sole benefit of the Reporting Person. The shares of Common Stock subject to the option vested fully on June 1, 2023. The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 13, 2024 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date. Carlos V. Paya, by /s/ Ron A. Metzger, Attorney-in-Fact 2023-11-09